Highlights

  • IperionX confirmed its ongoing commercial-scale titanium production in Virginia is advancing through customer qualification phases.
  • The company’s patented titanium technologies have received multiple U.S. government awards and nearly USD 160 million in funding, including SBIR Phase III, ARPA-E, and Defense Production Act Title III programs.
  • IperionX’s Virginia Titanium Manufacturing Campus has increased its projected capacity from 125 tpa to 200 tpa, with plans to reach approximately 1,400 tpa by mid-2027.
  • The Titan Critical Minerals Project is on track to become shovel-ready by mid-2026.

IperionX Limited (NASDAQ:IPX) (ASX:IPX) shares fell 8.2% to AUD 5.15 on 17 November 2025, as the company responded to a short seller report released by Spruce Point Capital Management. The announcement detailed IperionX’s ongoing titanium production scale-up, validation of its patented technologies, and support from multiple U.S. Government programs.

IperionX Addresses Short Seller Report

IperionX confirmed that Spruce Point Capital did not engage with the company before releasing its report. The company emphasized its compliance with continuous disclosure requirements under ASIC, ASX, and SEC rules. IperionX highlighted its rigorous confidentiality, data-security, and intellectual-property controls, meeting U.S. Department of War contracting standards.

The company reiterated its focus on commercial-scale titanium production in Virginia, with operations advancing through customer qualification phases. IperionX stated that it will continue updating the market in line with regulatory obligations.

Validation of Patented Titanium Technologies

IperionX’s technologies have received multiple awards and funding from U.S. Government programs, including ARPA-E, Defense Production Act Title III, IBAS, and SBIR Phase III contracts. These programs involve competitive selection, technical due diligence, and ongoing performance assessments by U.S. Department of War experts.

Notable recognitions include winning the U.S. Air Force Research Laboratory’s Grand Challenge in 2023, receiving a 2023 R&D 100 award, and securing nearly USD 160 million in combined government funding. This support spans industrial-scale titanium production, titanium powder innovation, and development of the Titan Critical Minerals Project in Tennessee.

Operational Focus and Market Expansion

IperionX’s Virginia Titanium Manufacturing Campus has increased its projected capacity from 125 tpa to 200 tpa, with plans to reach ~1,400 tpa by mid-2027 under IBAS funding. The company continues to deliver titanium components for defense and commercial customers, including Ford automotive programs, Panerai watches, and U.S. Army platforms.

IperionX’s strategy leverages patented HAMR and HSPT processes to produce high-performance titanium components at lower costs, using upgraded titanium scrap and mineral feedstocks. The Titan Critical Minerals Project is progressing toward ‘shovel-ready’ status by mid-2026.

Financial Position and Management

As of 30 September 2025, IperionX held USD 79.2 million in cash and equivalents, with access to additional funding through government programs.